4197.TWO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

DCF fair valuemodel estimate

Intrinsic value

$7.12

Price

$9.24

Implied downside

-23%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
4197.TWOVisgeneer Inc.	$9.24	+0.54%	$279M	—
4115.TWOSunder Biomedical Tech. Co., Ltd.	$7.38	+1.93%	$443M	—
4170.TWOVectorite Biomedical Inc.	$12.55	+0.80%	$549M	—
4183.TWOEPS Bio Technology Corp.	$13.05	-1.14%	$311M	—
6549.TWOTaiwanJ Pharmaceuticals Co., Ltd.	$6.93	+0.43%	$555M	—
6621.TWOUniPharma Co., Ltd.	$11.55	+0.43%	$416M	—
6661.TWOWelgene Biotech Co.,Ltd.	$16.00	-3.61%	$373M	—

Source: Financial Modeling Prep · peers by sector/industry

Visgeneer Inc.

Visgeneer, Inc. engages in the provision of biotechnology service. It specializes in blood glucose testers, blood glucose test tablets, blood ketone testers, blood ketone test tablets, and and skin care products. The company was founded on November 15, 2005 and is headquartered in Hsinchu, Taiwan.

www.visgeneer.com

Employees: 98
IPO / List date: Oct 24, 2013
HQ: TW

Held by traders on TradeandTell

No one on the platform currently holds 4197.TWO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 4197.TWO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 4197.TWO yet.